Anmol is a neuroscientist-entrepreneur, with over 7 years of expertise studying the biology of disorders like Fragile X Syndrome. He has experience creating genetic models of brain disorders and repurposing therapeutics to treat them.

Anmol received his MSc at McGill University and recently completed a Graduate Diploma in Business from Smith School of Business (Queen’s University). He is presently the Venture Associate for Bio at District 3 Innovation, where he helps life sciences startups in the ecosystem.